Viemed Healthcare Reports 12.2% Revenue Growth

The Lafayette-based provider of in-home respiratory care posted $80.7 million in net revenue as of September 30.

Updated on Nov. 5, 2026 in Healthcare

Isometric editorial illustration of three plain white home oxygen concentrators stacked on a pale wooden shelf with coiled clear tubing draped over them. — Viemed Healthcare reported $80.7 million in net revenue as of September 30, up 12.2% from a year earlier, and repurchased 115,000 shares for about $1 million. AI Illustration. Upload story photo >

Viemed Healthcare, based in Lafayette, reported net revenue of $80.7 million as of September 30, up 12.2% from a year ago and an $8.8 million increase over the prior-year third quarter. The company also repurchased 115,000 common shares for about $1 million during the quarter.

Why it matters

The results reflect growth in the company's in-home medical equipment and post-acute respiratory services across the U.S., with rising patient counts in several therapy categories. The share repurchase and debt repayment show how the company allocated cash during the period.

Viemed ended the quarter with $9.7 million in cash after repaying $2.1 million of term debt and repurchasing 115,000 shares for about $1 million. Ventilator patients reached 12,552 and rental revenue rose 7.4% to $3.5 million, though the report does not address forward guidance.

The players

Viemed Healthcare

A Lafayette-based provider of in-home medical equipment and post-acute respiratory health care services throughout the U.S.

The details

Viemed reported the results in its earnings report released Wednesday, November 5, 2025. Its stock closed at $10.11 on Tuesday and $9.45 on Wednesday.

Q3 2025: Viemed reported an $8.8 million increase in net revenue versus the prior year.
September 30, 2025: Viemed's net revenue reached $80.7 million and patient counts were reported as of this date.
Wednesday, November 5, 2025: Viemed released its earnings report.

Roadmap

Viemed's growth in home-based ventilator, PAP and sleep therapy patients fits a broader shift of respiratory care from hospital settings to the home. Its patient counts suggest the company is participating in that move rather than departing from it.

Patients relying on in-home ventilator, PAP or sleep therapy equipment from Viemed may see the company's continued expansion in those services. The report does not indicate changes to pricing or how patients obtain equipment.

The takeaway

Growth in home-based respiratory care reflects a patient preference for treatment outside hospitals, and readers tracking healthcare providers can watch whether these patient-count gains continue in future earnings reports.